Most authors who have treated short children with androgens have refrained from claiming that an increase in predicted height will be followed by an impoved adult height. Our results demonstrate that an increase in predicted height after androgen therapy definitely does not portend an increase in adult height. In warning against over optimistic interpretation of changes in predicted height resulting from androgen therapy, Bongiovanni (4) suggested that a rapid advance in bone age might occur once therapy was discontinued, although skeletal maturation was not unduly accelerated during therapy. We were able to study the progress of skeletal maturation of eight boys, two of whom seemed to have such an acceleration, but the others did not and continued to have predicted heights greater than pretreatment predicted height for as long as they were followed.
Our results have an additional implication for the evaluation of therapies designed to affect adult height in children with severely delayed bone ages. Because 50% of such boys fail to attain at least their predicted height less 5.1 cm, a treatment having no effect on predicted height but causing all treated children to reach their predicted height as adults would represent a significant improvement in outcome for these children. Thus, follow-up until adult height is attained is required before a therapy can be deemed effective or ineffective. Bronchial hyperreactivity has been recognized as a significant factor in causing the clinical symptoms of the asthmatic syndrome (1) . For testing this phenomenon by non-specific challenges, standardized methods have been developed. These include the use of pharmacologically active agents and exercise (8, 1 1, 12, 36) .
The mechanism by which exercise causes bronchoconstriction was closely linked to the effect of airway cooling, produced by an increased heat exchange during voluntary hyperventilation with subfreezing air (39, 40, (13) (14) (15) (16) . Although the final pathways for exercise and CACh are not fully understood, reliable separation of adult patients with asthma from healthy controls was possible by CACh (17) . Because the asthmatic syndrome in children and adults is basically similar and because of the growing evidence of different pediatric respiratory diseases being followed by bronchial hyperreactivity, the need exists for a conclusive study of CACh in children.
The investigation reported here was aimed at: 1 ) establishing the feasibility of CACh for testing bronchial hyperreactivity in children, 2) examining the discriminative power of the test between children with the asthmatic syndrome and healthy controls, and 3) testing the reproducibility and time course of cold air-induced reactions. The usefulness of this test in studying the nature as well as the limits of hyperreactivity was also explored.
MATERIALS AND METHODS
A group of 23 children with asthma (group A) and a group of 18 healthy control (group HC) children participated in the study.
Group A consisted of 14 boys and 9 girls (mean age, 1 17/~2 yr; range, 7%2 to 15%2). Fifty children had been randomly selected from 250 attending the outpatient asthma clinic. Of these, 27 were excluded for the following reasons: 12 were too young for pulmonary function testing, 5 had seasonal symptoms, 4 resided too far from the hospital, 2 were unwilling to participate, and 4 required regular systemic corticosteroid therapy. All 23 patients in Group A met the clinical definition of the asthma syndrome (I), having had repeated episodes of reversible intrathoracic airway obstruction with typical findings by PIT. They required medication with various drugs under regular supervision; however, none received systemic corticosteroid treatment. Fourteen of 20 patients tested had two or more positive skin reactions to common allergens. Nineteen children had a history of exercise induced bronchospasm, seven of them responded more severely to outdoor exercise in the winter.
Group HC consisted of 12 boys and six girls (mean age, 1 1 10/i2 yr; range, 65/12 to 148/~2) carefully evaluated by a uniform questionnaire for negative personal and family history of respiratory and allergic disorders. They never smoked and had no respiratory tract infections for at least 6 wk before the study. Informed consents were obtained from parents and children of both groups.
Patients in Group A were requested to discontinue treatment with sodium chromoglycate and inhaled corticosteroids 3 wk prior, with oral theophyllines 3 d prior, and with inhaled sympathomimetics 24 h before the investigation. By chance, none of the patients had sufficiently bothersome symptoms during the off-medication period to indicate their exclusion from the study.
CACh was given by a home built equipment similar to the one described by Simonssen et al. (37) . Two rectangular polyethelene tanks, one inside the other, insulated with styrofoam and with overall dimensions of 75 X 50 cm, served as a container for a dry ice-in-acetone bath. A 5-cm diameter, 1-mm thick, 140-cm long coiled copper tube was inserted through holes in the lid of the inner container and submerged in the bath when the lid was closed. The outlet was equipped with a two-way valve, a thermistor probe and the mouthpiece. On the expiratory side of the valve the sampler from a C02 analyzer (Jaeger C02-Test) provided for continuous monitoring of the expired air, and a ventilometer (Draeger) measured minute ventilation. Through the inlet side of the copper tube enough C 0 2 was continuously added during the test to keep the patient eucapnic. With this arrangement, inhaled air temperatures of -10 to -20°C could be maintained. During cold air inhalation for 4 min, the subjects were continuously coached to hyperventilate at 75% of their MVV level, as calculated from FEVl and monitored by the ventilometer.
Instead of dry air from a tank, room air was used for hyperventilation because the children objected to the "taste" of the compressed air, and because when the air with an average room temperature of +20 k 2°C and 60 + 10% relative humidity was cooled to around -15"C, the very low absolute water content imposed an almost equal evaporation-related thermal burden on the respiratory mucosa as would have dry air.
PFTs were done for baseline (prechallenge) determinations and for measuring the responses to challenges on a water-filled spirometer (Jaeger Spiro-Junior), by a helium dilution method on a direct read-out instrument (Jaeger FRC-Test), and on a pneumotachograph spirometer and X-Y recorder (Jaeger Pneumotest Junior). Recording and evaluation were done in accordance with standardized guidelines (42) . The children performed all manoeuvres in the sitting position wearing a nose clip. The functions measured or calculated were: VC, FRC, RV, TLC, Y C , FEVI FEF25-75, , PEF, VE~~~~O%VC;MEFV, V E~~~~~% T L~-M E V~max-1sovol60%TLC-MEFY, V E~~~~~~% V C -M E F V , V I~~~~O % V C -M I W , midVCratio and VE,,,,x25%vc.p~w. Results were expressed as percent of predicted normals based on accepted reference standards (34, 38, 45) .
Histamine inhalation challenge was given with CACh by a standardized procedure (8) . Histamine acid phosphate aersol, produced by a jet type nebulizer (Wright), was inhaled in up to nine dosage steps (0.03-10.0 mg/ml) at 3-min intervals. FEV, was measured 2.5 min after each inhalation. The series was complete at the concentration which caused a 20% or greater fall in FEVI. The PC20-h,stam,,,e value was obtained by linear interpolation between the last two points of the log dose-response curve ( 1 1, 35) . PITS before and 3-5 min after the last inhalation were measured as for CACh. Recovery was recorded by spirometry in 5-min intervals for 30 min or until FEVl reached at least 95% of the pre-HCh value.
The sequence of testing comprised the following 13 steps: 1) The subjects of both groups had a 30-min rest in the laboratory (20"C, 60% relative humidity) between 8:00 AM and 9:00 AM.
2) The children were trained in PFT manoeuvres until performing with maximal effort as judged by reproducibility. 3 ) Baseline PFTs were performed in triplicate in the following order: FRC, VC, FVC, and after a 5-min break, PEFV and MIFV-MEFV. 4) CACh was given. 5) The children were asked about their subjective feeling of "chest tightness" as a result of CACh. 6) Five minutes after the completion of the challenge, PEFV, MIFV-MEW, FVC, FRC, and VC were recorded. 7) Fifteen minutes after CACh the forced spirometric tests were repeated. 8 ) After a rest period of 2 h, the CACh procedure and the PFTs were performed for a second time. If children had required bronchodilator medication after CACh I, this interval was prolonged to 4 h. 9) Thirty minutes after the second CACh, FEV, was again measured in the children of Group A. If it was less than 100% of baseline or 80% of predicted value, bronchodilator medication was given. Salbutamol (Albuterol) (0.2 ml of the 0.5% solution per kg body weight, diluted to 2 ml) from a jet-type nebulizer (Pan-Inhalierboy 360 Nebulizer) was inhaled through a mouthpiece by slow tidal breathing. Fifteen minutes later, forced spirometric tests were performed again. 10) The results of each CACh were expressed in two ways: as actual PFT values after the challenge (in percentage of predicted) and as PFT changes induced by the challenge (in percentage of baseline).
In the following parts of the protocol, only children of Group A participated: I I ) During the week after the first two CAChs, the children measured and recorded their PEF twice a day on a Wright peak flow meter. The results were summarized as a mean and coeficient of variation for each child. 12) On 1 d, 2 wk after the first tests, a third CACh and a HCh were performed in random order after baseline PFTs as under step 3. Upon the completion of these challenges, Salbutamol was administered as under step 9. 13) After this day of testing, PEF was again measured for 1 wk as under step 1 1.
The statistical evaluation of all results was performed using the t tests for paired and unpaired samples and regression analyses by the least squares method. A P value 5 0.05 indicated a significant difference or correlation.
RESULTS
Altogether 52 CAChs and 18 HChs were done in Group A and 33 CAChs in Group HC. Five children with asthma appeared at one or another testing without a preceding break in medication; these tests are not included in the above total. Others, including three of Group HC, were absent from one or more testings. Different total numbers of patients in different categories of Tables 1-6 resulted from these exclusions and absences.
Two children in Group A had to be treated with a bronchodilator aerosol after CACh. One had unremitting discomfort associated with bronchoconstriction, the other could perform only one FEV-manoeuvre before requiring a bronchodilator treatment. This was the only one with an incomplete assessment protocol.
Baseline PFT results before each CACh are shown in Table 1 . The baseline values before three cold air challenges were comparable in each group; however, children in Group A demonstrated considerable intraindividual variation.
Cold air-induced changes in percentage of baseline values for pulmonary functions 5 min after all three challenges are shown in Table 2 . There was no overlap of individual changes between Groups A and HC in seven forced expiratory flow tests (FEV,, FEF25-75, VErnax50%-MEFV, V~m a x 6 0 %~~~-~~F V , V E~~~-~~~~O I .~O % T L C -M E N , VE~~~ZS%VC-MEFV, and V E~~~Z~% V C -P E F V ) .
The limits of "normal" reactions, defined by decreases in mean percentage of baseline plus 2 SD in the HC group were the following: -9% for FEV,, :21% for FEFZS-,~, -26% for VE~~~SO%VC-MEFV, -31% for
-26% for vEmax25%VC-PEW. The responses measured 5 min after the challenges expressed in percentage of predicted values for the seven most discriminative parameters are shown in Table 3 . After all three challenges the highest degree of abnormality occurred in small volumerelated flow rates. When expressing the results in this way, there was some overlap between the two groups.
In Figure 1 , correlations of baseline values with cold air induced changes, in percentage of baseline, for seven expiratory flows are shown for Group A. Most of these were not statistically significant. For FEV, a significant negative correlation was found, suggesting a stronger reaction in those with more abnormal baseline values. The slopes of negative regression lines tended to be closer to horizontal for flow rates measured at lower lung volumes during the forced expiration, and for V E~~X~~% V C -P E F V a significant positive correlation was found, indicating a weaker response in subjects with more abnormal baseline values.
The reproducibility of induced bronchoconstriction in repeated CAChs was evaluated by comparing changes in percentage of baseline and after challenge values in percentage of predicted. Results of CACh I and I1 were correlated for Groups A and HC combined, as well as for those 13 asthmatics alone who also participated in CACh 111. In addition, long-term reproducibility was evaluated by comparing the results of CACh I and 111. Figure  2 compares the reproducibility of changes and of after challenge values for FEV, and V E m a x 2 5 %~C -M~~~. The temperature of inspired air was -17.0 + 5.9" C (range, -5 to -30°C) in the first challenge for Group A and -15.8 +-3.8"C (range, -9 to -21°C) for Group HC. In six subjects of Group A and in three of Group HC, the air temperature was outside the range of -10 to -20°C. In the second challenge the temperatures were -15.0 & 4.S°C (-9 to -26°C) for Group A and -13.3 +. 3.3"C (-8 to -21°C) for Group HC, with two challenges in A and 2 in HC outside the target range. In the third challenge the temperatures were -12.3 + 3.1 "C (-7 to -18°C) with two outside the target range. In 16 children with asthma, two cold air provocations were performed on the same day. Except for one child who ventilated with identical inspiratory air temperatures in both procedures, all cold air-induced changes after CACh with the lower inspiratory air temperature were significantly different from those with the higher temperature for the higher inspiratory air temperature (60.7 + 21.9% versus 65.4 + 2 1.5%, P < 0.05), but this was not the case for VEm,,25,v,ME, (28.9 + 18.7% versus 29.5 -+ 15.1%).
After the first CACh, six children of Group A denied any sensation of tightness in the chest. FEV, changes in this subgroup ranged from -12 to -22% of baseline. In 10 asthmatics grading their airway obstruction as "mild," the change of FEV, was -17 to -53%, in six "moderate" -17 to -52% and in one child who experienced dyspnea it was -65% of baseline. The latter was the only child with a baseline FEV, under 60% of predicted. Fifteen minutes after the first CACh only one child felt a moderate, and six a mild tightness in the chest.
The response to the bronchodilator aerosol was assessed in 20 children of Group A. Eight were mediated at the end of the first day of testing, seven after the second, and five after both. Means of PEF-recordings during the week after the first CACh ranged from 76-135% of predicted with coefficients of variation of 2 to 35%. After the third CACh and the HCh mean PEFs were 78 to 132% of predicted and the coefficients of variation 3 to 31%. Both mean PEFs and the coefficients of variation correlated better with the after challenge values of FEV, and VE~~~ZS%VC-MEFV in percentage of predicted than with the challenge-induced changes in percentage of baseline (Table 5) . Eighteen children with asthma underwent an HCh. In each case a CACh was done on the same day. Eleven times the CACh was done first, seven times the HCh. All children responded positively to histamine as defined by at least a 20% baseline fall in FEV,. For the whole group PC20.hisrnmine was 2.06 f 2.79 mg/ ml (range, 0.28-10.0 mglml) ( Table 6 In contrast to the results after CACh, PC20ai,,ine did not correlate with either the mean or with the coefficient of variation of the PEF values recorded during the week after testing. In those five children of Group A who had CAChs done both with and without a preceding medication break (three being treated with chromolyn sodium and two with a combination of an inhaled sympathomimetic, a topical steroid and an oral theophylline) the cold air-induced changes and the post-CACh abnormalities were invariably larger when unmedicated. VE~~~ZS%VC-MEFV VEmax25%V~.PEFV) clearly distinguished between healthy children and those with asthma. The limits of repsonses in healthy subjects found in this study are outside the average intrasubject variability of the appropriate PFT measurements (21) , and they closely approximate the corresponding limits for exercise bronchoprovocation testing in children (23) . Such power of discrimination was also found for adults (1 7). The no overlap of cold air-induced responses between groups in this study is most likely attributable to strict selection criteria for both groups. In an unselected pediatric population an intermediate group between healthy and clearly hyperreactive individuals, such as in the case of adult hay fever patients (17) could exist.
TLC only increased to a minor extent after CACh. Consequently VE~~X-~OVO~.~O%TLC-MEFV did not differ from VEmax60%~~~-AS FVC showed a general tendency to decrease after CACh, VEma, measured at various isovolume points of prechallenge FVC would have rendered the induced changes as well as postCACh abnormalities more rather than less conspicuous.
The fact that partial and maximal flow-volume curves were comparable suggests that the volume history of the lung, which theoretically could influence the results (19, 30) , has little relevance in the clinical use of the method. The minor decrease of inspiratory airflow in the asthmatics supports the previous observation that children with recurrent croup do but those with asthma do not demonstrate significant inspiratory flow limitation after histamine inhalation (43) .
As heat flux from the airway surface depends on convective as well as evaporative losses, respiratory heat exchange is enhanced both by low temperature and water content of the inhaled air (1 3, 14,39 ). In the present study air was not dried before cooling for convenience's sake, but the absolute water content of air at sub-zero temperatures is so low that evaporation-dependent heat loss must have been maximal. Abnormal responses to cold-air provocation were not restricted to children with a history of exercise-induced asthma, although the test can, in part, be viewed as a model for it (18) . Previous laboratory studies on the incidence of this phenomenon in children produced inconsistent results, probably due to uncontrolled climatic factors (3, 23, 24, 29, 36) . This has limited the practical usefulness of even standardized exercise bronchoprovocation (12, 36) for the assessment of airway hyperreactivity in children (29) . In the present study all 23, randomly selected, patients of a pediatric asthma clinic demonstrated a reaction to cold air hyperventilation which exceeded that of healthy control subjects. Airway hyperreactivity to induced respiratory heat loss apparently is, thus, a general phenomenon in childhood asthma, with a sensivity superior to exercise. Some investigators suggested a "temperature-dependent" group of children reacting mainly to heat loss, and an "exercise-dependent" one reacting predominantly to exercise per se (4, 5) . This was explained by assuming that in the "temperature-dependentWgroup airway cooling affects mast cells located in more central airways, whereas exercise affects the more peripherally located ones (5) . In the present study, much colder inspiratory air temperatures were reached than in the ex~eriments leadinn to the above theorv, thus, respiratory heailoss will have deeper into -the tral cheobronchial tree, thereby reaching peripheral as well as central target systems.
Only about one-third of the patients reacted excessively to outdoor exercise in the winter. Theoretically this apparent contradiction could be explained by an adaptation to cold air after prolonged exposure. Children could also have a limited and variable perception of their airflow limitation, such as found in adult asthmatics (7, 27) . This possibility is supported by considerable interindividual differences in the subjective grading to chest tightness in the present study.
Evidence of a predominant contribution of small airways to cold air-induced expiratory airflow obstruction is given by greater changes in small airway-related flow rates. This predominant role of small airway obstruction can also be seen in the mean baseline values, which decreased towards the end of forced expiration, and in the effect of a bronchodilator medication which was least complete as measured by V E~~~Z S % V C .
Furthermore, flow rates late during forced expiration recovered slower after the provocation than FEV,. Others found long-lasting obstruction of the peripheral airways acting as a precondition for further asthmatic attacks (27) . In asthmatic children, characteristic impairment of flows measured late during forced expiration was also shown (20, 44) ; thus, cold air-induced airway reaction seems to accurately reflect localized events of the clinical disorder, rendering it an appropriate model for studying the disease.
The occurrence of considerable small airway reaction without major discomfort might, in part, be explained by a relatively small concomitant reaction in the large airways. Others have also observed that subjective complaints are predominantly dependent on large airway obstruction (27) .
The present study demonstrated different baseline-to-response correlations for different flow measurements. A negative correlation was found for FEV, but a positive one for V E~~~~S % V~-P E N . This tendency for FEV1 might, in part, be the arithmetic result of relating a given absolute decrease of FEV, to a varying baseline value. But, the opposite tendency for v~rnax25%~~.PEW, which changed relatively less in patients with a lower baseline, indicates the existence of some "reaction-limiting" mechanism. Others have also speculated on such mechanisms when studying histamine challenge (10) .
The results of cold air provocation in this study were expressed both as changes in percentage of baseline, and as postchallenge abnormalities in percentage of predicted values. Maximum flows recorded towards the end of the forced expiration were markedly more reproducible in form of the latter than of the former expression. This reproducibility even exceeded the one of some baseline measurements. The same was true when comparing CACh I and 111. This again indicated an individual limitation of the reaction, most likely determined by some characteristics of the peripheral airways. The poorer reproducibility of results over a 2-wk period indicates spontaneous changes of reactivity.
In asthmatic adults a dose-response relationship for respiratory heat exchange and expiratory airflow changes was found (3 1). In the children studied here, respiratory heat exchange was not accurately quantified, as the expired air temperature was not measured; however, for FEVI, a trend towards lower values after CACh with the colder inspired air suggested such a dose-response relationship. No such trend was found for maximum flow at low lung volume (VErnax~S%vc.M~W). Baseline-to-response correlations, reproducibility characteristics, and temperature-to-response interrelations all indicate a different dose-response behavior for different flow measurements. The cold air-induced change of FEVI apparently took place on the steep mid-portion of its doseresponse curve, resulting in more obstruction after a large dose. In contrast, the small airway-related flows were most likely shifted to the flatter upper part of a sigmoid dose-response curve. There, variations of respiratory heat exchange would not have a major effect. This divergent behavior of large and small airwayrelated flows could be explained by either a steeper mid-portion of the small-airway dose-response curve, or by a more obstructed baseline situation in the periphery, or both. If the limit of doseresponse presumably reached by CACh, represents a genuine maximum of small airway reaction, the determinants of this maximum remain unknown. Merely mechanical limitations should have resulted in better reproducibility of stronger reactions to CACh. If, however, the maximum obstruction is determined by individual and variable intrinsic responsiveness, a smaller CACh-induced obstruction in one child should be as reproducible as a larger one in another. Figure 2 , indicating that the scatter of points for less obstruction was not more than that for higher airflow limitation, seems to support the latter hypothesis. It may be assumed that the endogenously predetermined maximum of small airway obstruction is linked to the momentary limit of individual airway hyperreactivity. Indeed in this study the absolute short-range after-challenge abnormality is highly reproducible and independent of the variable baseline situation.
The total range of responsiveness in asthmatic children can not be estimated if their individual "normal" pulmonary functions are not known. Because predicted mean values by height cannot account for interindividual differences in post-CACh values expressed as percentage of predicted, overlaps of individual results between A and HC occurred. This can be explained by the following example: in an asthmatic (or hyperreactive) child with a baseline of 1 14% predicted for FEV,, a postchallenge response of 24% would produce a value of 87% of predicted. In a healthy child with a baseline of 91% of predicted, a 4% of baseline change would result in the same end-point. Clearly then an individual child's airway reactivity can only be determined by percentage of predicted after challenge values if the absolute baseline is known. The latter could be estimated by a functional optimum produced with a bronchodilator medication. Responses to challenge could then be expressed as percentages of this individual optimum. In the present study, this could not be done reliably because bronchodilator was administered after the challenges.
Airway hyperreactivity is frequently measured by challenges with histamine or metacholine. The procedures have been standardized (8, 1 1, 35 ). The response is described by the drug concentration producing a predetermined change of lung function (e.g., a 20% fall of FEVI). The disadvantages of this meth- the time course of recovery after a positive reaction to histamine is highly variable. The response may not be related strictly to either the last inhaled drug concentration or to the accumulated dose of all inhalations (25) . The complicated interrelation between baseline functions and response is poorly understood (10, 25) . Drugs used in these inhalation challenges can, in high dosages, reduce lung function beyond the 20% limit in anyone, raising doubts about the specificity of such tests.
Although in a standardized inhalation challenge the highest bronchoconstrictor dose might cause a reaction greatly overshooting the target value, after CACh only one child showed marked and promptly reversible dyspnea. Children like this with a baseline FEV, below 60% of predicted should not be tested.
In comparison to pharmacologic challenges, CACh is less time consuming, void of problems with aerosol generation and deposition, yet it discriminates clearly between "normal" and hyperreactive individuals. It seems to be an acceptable model of childhood asthma and, for some lung functions, the response is independent from the baseline situation. Simulating hyperventilation on a cold winter day is also more physiologic and, thus, ethically more acceptable than the inhalation of pharmacologically active substances.
All children with asthma responded positively to both CACh and histamine but with no quantitative correlation of the results. In previous studies, close correlations between the responses to inhaled histamine and metacholine (9, 22) , and between exercise and metacholine challenges (9, 26) were found. Opinions differ about the correlation of airway reactivity induced by histamine and exercise (2, 9, 23) .
The clinical usefulness of CACh is supported by the significant correlation found between the responses and PEF measurements during the week after the provocation. Such measurements did not correlate well with the results of the histamine challenge. Whether or not longer observation periods with PEF testing would have revealed a more accurate picture of the patient's condition, the observed differences between different phases of the study and between results expressed in different ways must be regarded as relevant. Cold air provocation might be superior to histamine challenge in characterizing the clinical severity of childhood asthma.
Five children who were tested when under medication seemed to be partially protected. Drug interaction with the response to CACh will have to be studied systematically together with the still controversial cellular, humoral, and neural mechanisms of the reaction (5, 6, 18, 32) .
This new method of testing bronchial hyperreactivity, as adapted for use in pediatrics, can assist in the diagnosis of respiratory disturbances in children with atypical manifestations of asthma. In those with proven asthma a quantitative assessment of the level of reactivity could help in fine tuning of diagnostic and therapeutic decisions. It seems that cold air provocation can better characterize the physiologic abnormality than highly variable measurements of pulmomary functions (28) . Using a bronchodilator for determining the child's individual functional optimum it is now possible to establish the whole range of "functional dimensions" of a child's asthma (Fig. 3) . Whether, and to what extent the response of CACh is representative of responses to other triggering factors, including exercise, remains to be evaluated. At the present time one can only speculate about the nature and time course of the interrelations between baseline lung fucntions, a postbronchodilator tested optimum and the limits of reactivity.
